Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 95.85% is in line with its 5-year average of 93.33%, near the high end of its 5-year range (45.05%–98.91%).
16.05% above its 12-month average of 82.59%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 94.47%.
GROSS MARGIN
95.85%
GROSS MARGIN AVG TTM
82.59%
GROSS MARGIN AVG 3Y
93.41%
GROSS MARGIN AVG 5Y
93.33%
GROSS MARGIN AVG 10Y
94.60%
GROSS MARGIN AVG 15Y
70.42%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+16.05%
CURRENT VS 3Y AVG
+2.61%
CURRENT VS 5Y AVG
+2.70%
CURRENT VS 10Y AVG
+1.32%
CURRENT VS 15Y AVG
+36.11%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+132.62%
vs the sector median at left
PTC Therapeutics, Inc.
Market Cap
$5.32B
Gross Margin
95.85%
TTM Avg
82.59%
3Y Avg
93.41%
5Y Avg
93.33%
Market Cap
$5.21B
Gross Margin
-6537.01%
TTM Avg
-3376.01%
3Y Avg
-7968.48%
5Y Avg
-11525.78%
Market Cap
$5.21B
Gross Margin
94.41%
TTM Avg
97.28%
3Y Avg
95.66%
5Y Avg
96.11%
Market Cap
$5.20B
Gross Margin
54.72%
TTM Avg
55.10%
3Y Avg
55.18%
5Y Avg
55.10%
Market Cap
$5.19B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-37.83%
Market Cap
$5.52B
Gross Margin
53.85%
TTM Avg
55.16%
3Y Avg
56.69%
5Y Avg
56.69%
Market Cap
$5.09B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-67.67%
5Y Avg
-188.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | $5.32B | 95.85% | 82.59% | 93.41% | 93.33% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | -6537.01% | -3376.01% | -7968.48% | -11525.78% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | 94.41% | 97.28% | 95.66% | 96.11% |
| Sotera Health Company (SHC)vs › | $5.20B | 54.72% | 55.10% | 55.18% | 55.10% |
| Doximity, Inc. (DOCS)vs › | $5.20B | 88.07% | 89.65% | 88.97% | 88.20% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | 0.00% | 0.00% | 0.00% | -37.83% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 53.85% | 55.16% | 56.69% | 56.69% |
| RadNet, Inc. (RDNT)vs › | $5.53B | 9.70% | 9.04% | 10.84% | 11.30% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | 0.00% | 0.00% | -67.67% | -188.00% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 49.52% | 48.04% | 46.91% | 45.73% |
Gross Margin
95.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 94.47% |
| 2026-03-31 | 89.72% |
| 2025-12-31 | 90.10% |
| 2025-09-30 | 45.05% |
| 2025-06-30 | 93.62% |
| 2025-03-31 | 98.91% |
| 2024-12-31 | 92.36% |
| 2024-09-30 | 94.49% |
| 2024-06-30 | 91.68% |
| 2024-03-31 | 92.98% |
| 2023-12-31 | 65.38% |
| 2023-09-30 | 95.17% |
| 2023-06-30 | 94.05% |
| 2023-03-31 | 93.58% |
| 2022-12-31 | 93.49% |
| 2022-09-30 | 93.55% |
| 2022-06-30 | 94.18% |
| 2022-03-31 | 93.19% |
| 2021-12-31 | 94.36% |
| 2021-09-30 | 95.29% |
| 2021-06-30 | 93.69% |
| 2021-03-31 | 92.28% |
| 2020-12-31 | 95.89% |
| 2020-09-30 | 96.06% |
| 2020-06-30 | 92.95% |
| 2020-03-31 | 94.02% |
| 2019-12-31 | 96.33% |
| 2019-09-30 | 95.79% |
| 2019-06-30 | 96.25% |
| 2019-03-31 | 95.57% |
| 2018-12-31 | 95.64% |
| 2018-09-30 | 93.86% |
| 2018-06-30 | 96.26% |
| 2018-03-31 | 94.57% |
| 2017-12-31 | 96.88% |
| 2017-09-30 | 96.22% |
| 2017-06-30 | 98.42% |
| 2017-03-31 | 99.85% |
| 2016-12-31 | -0.08% |
| 2016-09-30 | -36.59% |
| 2016-06-30 | -84.40% |
| 2016-03-31 | -66.18% |
| 2015-12-31 | -175.23% |
| 2015-09-30 | -213.48% |
| 2015-06-30 | -342.68% |
| 2015-03-31 | -416.70% |
| 2014-12-31 | -131.61% |
| 2014-09-30 | -2254.45% |
| 2014-06-30 | -1191.47% |
| 2014-03-31 | -73.71% |
| 2013-12-31 | -282.11% |
| 2013-09-30 | 10.15% |
| 2013-06-30 | -150.72% |
| 2013-03-31 | -85.39% |
| 2012-12-31 | 112.19% |
| 2012-09-30 | 119.07% |
| 2012-06-30 | 125.08% |
| 2012-03-31 | 116.48% |
